Carlotta Giani

Livorno, 57121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Treatment with Kinase Inhibitors Plus Myo-Inositol as Re-Differentiating Agents in Iodine-Refractory Thyroid Cancers.

Treatment with Kinase Inhibitors Plus Myo-Inositol as Re-Differentiating Agents in Iodine-Refractory Thyroid Cancers.

Journal: Life (Basel, Switzerland)

Published: January 14, 2026

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study).

Journal: European thyroid journal

Published: December 11, 2024

The potential role of neoadjuvant treatment in thyroid cancers in the era of kinase inhibitors: a narrative review.

The potential role of neoadjuvant treatment in thyroid cancers in the era of kinase inhibitors: a narrative review.

Journal: Endocrine

Published: October 23, 2024

Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report.

Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report.

Journal: Frontiers in endocrinology

Published: February 21, 2024

Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.

Hand-foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer.

Journal: European thyroid journal

Published: January 09, 2024

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.

Journal: Journal of endocrinological investigation

Published: January 11, 2023

Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma.

Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma.

Journal: Thyroid research

Published: October 07, 2022

Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test.

Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test.

Journal: Journal of endocrinological investigation

Published: August 09, 2022

Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.

Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.

Journal: Journal of endocrinological investigation

Published: June 05, 2021

Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.

Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 23, 2021

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.

Journal: International journal of molecular sciences

Published: February 10, 2021

[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival.

[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 07, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026